396 related articles for article (PubMed ID: 27641310)
1. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
[TBL] [Abstract][Full Text] [Related]
2. [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
Redondo E; Rivero-Calle I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Gil A; Molina J; Jimeno I; Ocaña D; Yuste JE; Martinón-Torres F;
Semergen; 2018; 44(8):590-597. PubMed ID: 30318406
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en Prevención Group].
Redondo E; Rivero-Calle I; Mascarós E; Yuste JE; Fernández-Prada M; Ocaña D; Jimeno I; Gil A; Molina J; Díaz-Maroto JL; Linares M; Martinón-Torres F;
Semergen; 2021 Sep; 47(6):411-425. PubMed ID: 34332864
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
Principi N; Esposito S
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.
Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M;
Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
[TBL] [Abstract][Full Text] [Related]
7. [Reasons for adult immunization -- prevention of most frequent respiratory infections].
Ludwig E
Orv Hetil; 2014 Nov; 155(44):1743-7. PubMed ID: 25344851
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
9. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines.
Nguyen-Van-Tam JS; Neal KR
Semin Respir Infect; 1999 Jun; 14(2):184-95. PubMed ID: 10391412
[TBL] [Abstract][Full Text] [Related]
11. Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia.
Mermond S; Berlioz-Arthaud A; Estivals M; Baumann F; Levenes H; Martin PM
Trop Med Int Health; 2010 Dec; 15(12):1517-24. PubMed ID: 20955369
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
14. Preventing pneumonia: the role for pneumococcal and influenza vaccines.
Shorr AF
Clin Chest Med; 2005 Mar; 26(1):123-34. PubMed ID: 15802174
[TBL] [Abstract][Full Text] [Related]
15. Lower respiratory tract infections: prevention using vaccines.
Whitney CG; Harper SA
Infect Dis Clin North Am; 2004 Dec; 18(4):899-917. PubMed ID: 15555831
[TBL] [Abstract][Full Text] [Related]
16. [Vaccinations from the pulmonologist's point of view].
Forstner C; Pletz MW
Internist (Berl); 2015 Jul; 56(7):838-46. PubMed ID: 26059891
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
18. [Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression.].
Guchev IA
Antibiot Khimioter; 2016; 61(7-8):48-57. PubMed ID: 29533560
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
20. [Pneumococcal vaccine recommendations in chronic respiratory diseases].
Casas Maldonado F; Alfageme Michavila I; Barchilón Cohen VS; Peis Redondo JI; Vargas Ortega DA
Semergen; 2014 Sep; 40(6):313-25. PubMed ID: 25107494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
